Abeona Therapeutics (ABEO) Current Deferred Revenue (2010 - 2021)
Abeona Therapeutics' (ABEO) quarterly Current Deferred Revenue came in at $296000.0 in Q4 2021, little changed year-on-year from $296000.0 in Q4 2020, and little changed quarter-over-quarter from $296000.0 in Q3 2021.
Abeona Therapeutics (ABEO) Current Deferred Revenue (2010 - 2021) Analysis & Trends
Abeona Therapeutics' Current Deferred Revenue history runs 12 years deep, the most recent figure standing at $296000.0 for Q4 2021.
- On a quarterly basis, Current Deferred Revenue changed 0.0% year-over-year to $296000.0 in Q4 2021; TTM through Dec 2021 was $296000.0, a 0.0% change from a year earlier, with the FY2021 full-year figure at $296000.0, changed 0.0% from the prior year.
- Current Deferred Revenue steadied at $296000.0 in Q4 2021 per ABEO's latest filing, from $296000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $2.6 million in Q4 2017 and bottomed at $296000.0 in Q4 2018.
- The 5-year median for Current Deferred Revenue is $296000.0 (2018), against an average of $560736.8.
- Across the five-year window, Current Deferred Revenue jumped 331.89% in 2017 and sank 88.62% in 2018, its largest moves.
- Year by year, Current Deferred Revenue stood at $2.6 million in 2017, then sank by 88.62% to $296000.0 in 2018, then changed by 0.0% to $296000.0 in 2019, then changed by 0.0% to $296000.0 in 2020, then changed by 0.0% to $296000.0 in 2021.
- Per Business Quant, the three latest ABEO Current Deferred Revenue figures stand at $296000.0 (Q4 2021), $296000.0 (Q3 2021), and $296000.0 (Q2 2021).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 296,000.00 |
| Sep 30, 2021 | 296,000.00 |
| Jun 30, 2021 | 296,000.00 |
| Mar 31, 2021 | 296,000.00 |
| Dec 31, 2020 | 296,000.00 |
| Sep 30, 2020 | 296,000.00 |
| Jun 30, 2020 | 296,000.00 |
| Mar 31, 2020 | 296,000.00 |
| Dec 31, 2019 | 296,000.00 |
| Sep 30, 2019 | 296,000.00 |
| Jun 30, 2019 | 296,000.00 |
| Mar 31, 2019 | 296,000.00 |
| Dec 31, 2018 | 296,000.00 |
| Jun 30, 2018 | 800,000.00 |
| Mar 31, 2018 | 1.60 Mn |
| Dec 31, 2017 | 2.60 Mn |
| Sep 30, 2017 | 602,000.00 |
| Jun 30, 2017 | 602,000.00 |
| Mar 31, 2017 | 602,000.00 |
| Dec 31, 2016 | 602,000.00 |